Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.

Journal Article (Journal Article)

The appropriate regimen of platelet inhibitors that should be used in patients with immune thrombocytopenia purpura (ITP; formerly called idiopathic thrombocytopenic purpura) who are undergoing percutaneous coronary intervention is unclear. We report the case of a patient with ITP who underwent two separate coronary interventions. The first involved the use of aspirin and a cutting balloon to treat obstructive disease of the left circumflex. When the patient presented with restenosis, he received eptifibatide, clopidogrel, and an intracoronary stent. He is currently 16 months removed from his second procedure and remains physically active without any anginal symptoms. Percutaneous revascularization in patients with ITP remains a challenge and this therapeutic approach, while ultimately successful in the patient, requires further validation.

Full Text

Duke Authors

Cited Authors

  • Stouffer, GA; Hirmerova, J; Moll, S; Rubery, B; Napoli, M; Ohman, EM; Simpson, R

Published Date

  • March 2004

Published In

Volume / Issue

  • 61 / 3

Start / End Page

  • 364 - 367

PubMed ID

  • 14988897

International Standard Serial Number (ISSN)

  • 1522-1946

Digital Object Identifier (DOI)

  • 10.1002/ccd.10799


  • eng

Conference Location

  • United States